Table 2.
ID | Gender | Age | Previous Hematological Malignancy or Chemotherapy | FAB | CD34 | Karyotype | Flt3 Mutation | NPM-1 Mutation | |
---|---|---|---|---|---|---|---|---|---|
Abnormality | Classification | ||||||||
Responders | |||||||||
1 | F | 45 | Chemotherapy | M4 | Negative | Normal | Normal | wt | ins |
2 | F | 63 | M4 | Positive | Normal | Normal | ITD | wt | |
3 | M | 72 | M5 | Negative | Normal | Normal | wt | ins | |
4 | M | 29 | Relapse | M4 | Positive | Normal | Normal | ITD | ins |
5 | F | 80 | M2 | Positive | Complex | Adverse | wt | wt | |
6 | F | 36 | M4 | Positive | Normal | Normal | wt | nt | |
7 | F | 75 | M1 | Positive | nt | ITD | wt | ||
8 | M | 71 | Relapse | M2 | Negative | Normal | Normal | G835 | |
9 | M | 35 | M2 | Positive | Normal | Normal | wt | wt | |
10 | M | 72 | Myelodysplastic syndrome | M1 | Positive | Complex | Adverse | wt | |
11 | F | 64 | Chemotherapy | M2 | Negative | Normal | Normal | ITD | ins |
12 | F | 59 | Chemotherapy | M5 | Negative | Normal | Normal | ITD | ins |
13 | M | 58 | M5 | Positive | Normal | Normal | wt | wt | |
14 | F | 59 | Chemotherapy | M4 | Negative | Normal | Normal | ITD | ins |
15 | F | 75 | M4 | Positive | Normal | Normal | ITD | wt | |
Non-responders | |||||||||
16 | F | 29 | Chemotherapy | M5 | Positive | Normal | Normal | ITD+Asp835 | wt |
17 | M | 24 | M2 | Positive | Multiple | Adverse | nt | wt | |
18 | F | 82 | M4 | Positive | Normal | Normal | ITD | wt | |
19 | F | 77 | M1 | Negative | nt | nt | ins | ||
20 | M | 84 | M1 | Positive | Multiple | Adverse | wt | wt | |
21 | M | 53 | M0 | Positive | 13 | Intermediate | wt | wt | |
22 | M | 65 | M5 | Negative | Normal | Normal | ITD | ins | |
23 | F | 46 | M1 | Positive | inv(16) | Favorable | wt | wt | |
24 | F | 70 | M4 | Negative | nt | wt | ins | ||
25 | M | 33 | Chemotherapy | M1 | Positive | Normal | Normal | wt | wt |
26 | F | 77 | M1 | Positive | nt | nt | wt | ||
27 | M | 76 | M0 | Positive | Normal | Normal | wt | wt | |
28 | M | 60 | M4 | Positive | Normal | Normal | ITD | wt | |
29 | M | 36 | M5 | Positive | +8, +22, inv(16) | Favorable | ITD | wt | |
30 | F | 67 | M5 | Negative | t(9,11), +19 | Intermediate | wt | wt |
The table shows the gender (M, male; F, female) and age (years) of the individual patients at diagnosis. The FAB classification was used to classify morphological and/or histochemical signs of differentiation. Cytogenetic abnormalities were classified according to the medical research council (MRC) criteria. The detection of Fms like tyrosine kinase 3 (Flt3) (ITD, internal tandem duplications) or nucleophosmin (NPM)-1 insertions (ins) is also indicated in the table. Complex karyotype means at least three abnormalities [1]. FAB: The French-American-British (FAB) classification system; nt: not tested; wt: wild type.